The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 15, 2020
Filed:
Jan. 16, 2018
Applicants:
University of Tennessee Research Foundation, Knoxville, TN (US);
Oncternal Therapeutics, Inc, San Diego, CA (US);
Inventors:
Duane D. Miller, Collierville, TN (US);
Jianjun Chen, Knoxville, TN (US);
James T. Dalton, Ann Arbor, MI (US);
Chien-Ming Li, Fremont, CA (US);
Sunjoo Ahn, Yuseong-gu Daejeon, KR;
Wei Li, Germantown, TN (US);
Assignees:
UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, Knoxville, TN (US);
ONCTERNAL THERAPEUTICS, INC., San Diego, CA (US);
Primary Examiner:
Int. Cl.
CPC ...
C07D 403/04 (2006.01); C07D 403/10 (2006.01); A61K 31/4025 (2006.01); A61K 31/404 (2006.01); A61K 31/426 (2006.01); A61K 31/421 (2006.01); A61K 31/4178 (2006.01); A61K 45/06 (2006.01); C07D 233/02 (2006.01); C07D 233/22 (2006.01); C07D 233/54 (2006.01); C07D 263/06 (2006.01); C07D 263/14 (2006.01); C07D 263/32 (2006.01); C07D 277/04 (2006.01); C07D 277/24 (2006.01); C07D 277/28 (2006.01); C07D 277/56 (2006.01); C07D 401/04 (2006.01); C07D 401/06 (2006.01); C07D 413/04 (2006.01); C07D 413/06 (2006.01); C07D 417/04 (2006.01); C07D 417/06 (2006.01);
U.S. Cl.
CPC ...
C07D 403/04 (2013.01); A61K 31/4178 (2013.01); A61K 31/421 (2013.01); A61K 31/426 (2013.01); A61K 45/06 (2013.01); C07D 233/02 (2013.01); C07D 233/22 (2013.01); C07D 233/54 (2013.01); C07D 263/06 (2013.01); C07D 263/14 (2013.01); C07D 263/32 (2013.01); C07D 277/04 (2013.01); C07D 277/24 (2013.01); C07D 277/28 (2013.01); C07D 277/56 (2013.01); C07D 401/04 (2013.01); C07D 401/06 (2013.01); C07D 413/04 (2013.01); C07D 413/06 (2013.01); C07D 417/04 (2013.01); C07D 417/06 (2013.01);
Abstract
The present invention relates to a compound of formula XXII and a compound of formula 17ya, which are defined as anywhere in the specification, to a composition comprising the same, and to a method of using thereof in the treatment of various forms of cancer.